Natural killer (NK) cells have traditionally been considered nonspecific components of innate immunity, but recent studies have shown features of antigen-specific memory in mouse NK cells. However, it has remained unclear whether this phenomenon also exists in primates. We found that splenic and hepatic NK cells from SHIV SF162P3 -infected and SIV mac251 -infected macaques specifically lysed Gag-and Env-pulsed dendritic cells in an NKG2-dependent fashion, in contrast to NK cells from uninfected macaques. Moreover, splenic and hepatic NK cells from Ad26-vaccinated macaques efficiently lysed antigen-matched but not antigen-mismatched targets 5 years after vaccination. These data demonstrate that robust, durable, antigen-specific NK cell memory can be induced in primates after both infection and vaccination, and this finding could be important for the development of vaccines against HIV-1 and other pathogens.
NK cells have traditionally been associated with nonspecific innate killing of virus-infected and neoplastic cells. However, increasing evidence suggests that NK cells also cooperate with adaptive humoral immune responses to mediate antibody-dependent cell-mediated cytotoxicity (ADCC) and modulate the responses of CD4 + and CD8 + T cells [1] [2] [3] [4] [5] [6] . In the specific context of HIV-1 infection, NK cells have been reported to proliferate during primary infection 7 before the development of CD8 + T cell responses. In addition, NK cells lyse HIV-1-infected cells through a variety of mechanisms such as ADCC 8 , downmodulation of major histocompatibility complex (MHC) class I molecules 9 and upregulation of ligands of NKG2D, a stimulatory NK cell receptor 10 . NK cells can also inhibit CCR5dependent entry of HIV-1 by secreting the β-chemokines CCL3, CCL4 and CCL5 (ref. 11) . In rhesus macaques, NK cells have been shown to lyse simian immunodeficiency virus (SIV)-infected cells 12 and SIV-pulsed cells 13 . Other studies have shown that acute infection of rhesus macaques with SIV mac251 induces rapid NK cell activation and increased cytotoxicity 14 , and longitudinal studies suggest that NK cells may be associated with the prevention of disease progression in SIV-infected macaques 15, 16 .
So far, antigen-specific NK cell memory has been described only in mice [17] [18] [19] [20] [21] [22] [23] . Mice lacking T and B cells develop immunologic memory for haptens and viral antigens that is mediated by a transferrable subset of liver-restricted NK cells 18, 19, 21, 23 . Certain activating receptors on human and murine NK cells have also been shown to recognize proteins from several viruses and to modulate disease [24] [25] [26] [27] . However, expression of those surface molecules on NK cells has not been associated with the acquisition of antigen-specific NK cell memory responses. Long-lived and transferrable memory responses against murine cytomegalovirus (MCMV) were shown to induce binding of the virus-encoded protein m157 to the activating receptor Ly49H on murine NK cells 28 , although antigen specificity was not formally tested in that study. Antigen-specific NK cell memory has not been demonstrated previously in any primate species, but a large body of work has long suggested that the NK cell response might not be entirely nonspecific. Increased NK cell antiviral functions in HIV-1-exposed seronegative individuals have been associated with protection 29, 30 , and uninfected infants of HIV-1-positive mothers can mount potent NK cell responses that are associated with blocking transmission in utero 31 , both of which indicate potential pre-sensitization to the virus. Similarly, killer immunoglobulin-like receptor (KIR)-MHC interactions have been shown to exert significant immunological pressure on HIV-1 replication, thereby driving virus evolution and escape 32 . During infection with human cytomegalovirus, NKG2C + CD57 + NK cells expand in a virus-specific manner 33 , and, similarly, CD27 + NK cells are associated with spontaneous control of the virus 34 , but no previous study has definitively shown acquired antigen specificity of NK cells in humans or other primate species. To address this deficit, in this study we assessed potential NK cell memory in both SIV-infected and long-term vaccinated rhesus macaques.
RESULTS

Identification and purification of rhesus macaque NK cells
We identified bulk NK cells as CD3 − CD14 − CD20 − HLA-DR lo NKG2A + mononuclear cells as described 15, 35, 36 (Fig. 1a ) and confirmed their identity by demonstrating coexpression of the NK cell-related markers CD8α, NKp30 and NKp46 (Fig. 1b) . Macaque NK cells also had the expected distribution of CD56 + and CD16 + subpopulations 15, 35, 36 (Fig. 1c) . To evaluate the antigen specificity of NK cells, we developed a flow cytometry assay to measure the ability of purified NK cells to lyse autologous dendritic cells (DCs). We purified NK cells from bulk mononuclear cells using magnetic beads and then sorted either A r t i c l e s CD3 − CD14 − CD20 − NKG2A + or CD3 − CD14 − CD20 − CD8α + NK cells by flow cytometry. This resulted in 99.5-99.8% pure NK cells with no detectable (0.00%) contaminating T cells ( Fig. 1d) . NK cells showed high expression of intracellular transcription factors Eomes and T-bet and the serine protease granzyme B, but they did not express CD27 ( Fig. 1e) . Given the highly overlapping phenotypes, it is possible that purified NK cells could contain minor frequencies of phylogenetically related innate lymphoid cell group 1 (ILC1) 37 , but as primate ILC1 cells generally do not express granzyme B, are CD27 + and have low expression of Eomes 38 , contamination is likely to be minimal. To confirm a lack of T cell contamination, we further analyzed purified NK cells by flow cytometry and found no detectable expression of the T cell markers CD5, TCRαβ and TCRγδ ( Fig. 1f) . Collectively, these data present a comprehensive definition of NK cells in rhesus macaques and validate our methodologies for highly efficient purification.
Antigen-specific NK cell responses in SHIV SF162P3 infection
To evaluate the ability of purified NK cells to lyse cells in an antigenspecific manner, we cultured NK cells with autologous DCs pulsed with antigens and labeled with the red dye PKH26. Cultures also contained unpulsed autologous DCs labeled with the green dye CFSE as internal controls ( Fig. 2a) . Although many NK cell-killing assays call for cultures of only 6 h, time-course experiments showed that maximum killing was achieved with an 18-h incubation in our study ( Fig. 2b) ; this might have been due in part to our use of frozen cells, differences among species or differences in the mechanism of 'innate' versus 'antigen-specific' killing by NK cells. Using this assay, we first tested the ability of purified splenic and hepatic NK cells from a cohort of eight macaques infected with simian-human immunodeficiency virus (SHIV) strain SF162P3 (SHIV SF162P3 ) to lyse DCs pulsed with SIV mac239 Gag or HIV-1 Env. Splenic NK cells killed DCs pulsed with Gag or Env (median specific lysis of 13% and 10%, respectively, at a 10:1 effector:target (E:T) ratio), but not cells pulsed with the irrelevant protein ovalbumin (Ova) (median specific lysis of 0.3% at a 10:1 E:T ratio) ( Fig. 2c) . Responses to the viral proteins were significantly different from those to Ova at both 10:1 (Gag, P = 0.015; Env, P = 0.001) and 5:1 (Gag, P = 0.017; Env, P = 0.023) E:T ratios. Hepatic NK cells showed a median specific lysis of 16-18% of Gag-pulsed DCs (Fig. 2d) . As an additional positive control, we also demonstrated that bulk NK cells, regardless of their antigen experience, were functionally capable of nonspecific lysis of MHC-devoid K562 cells, standard NK cell targets ( Fig. 2e) . These data confirmed that highly purified tissue NK cells from SHIV-infected macaques could recognize and lyse autologous DCs in an antigen-specific manner.
Antigen-specific NK cell responses in SIV mac251 infection
We next evaluated NK cells from a cohort of eight rhesus macaques chronically infected with SIV mac251 and six naive uninfected macaques. Splenic NK cells from infected animals were highly reactive to Gag-pulsed DCs at a 10:1 ratio with a median specific lysis of 40%, compared with 0.1% in uninfected age-matched controls ( Fig. 3a) (P = 0.018). In contrast, NK cells from SIV-infected animals were not reactive to unpulsed DCs (Fig. 3b) . These data demonstrate robust anti-Gag NK cell responses in the spleen of SIV-infected animals but not in uninfected animals, confirming true antigen specificity. Only marginal Gag-specific NK cell responses were observed in peripheral blood, although these responses were still slightly stronger than those observed in uninfected animals (P = 0.05) ( Fig. 3c) . These findings suggest that antigen-specific NK cells either are located primarily in tissues or possibly reflect sequestration in sites of higher antigen concentration. In a confirmatory assay, we found that CD107a was also specifically upregulated on splenic NK cells cultured with Gagpulsed DCs (Fig. 3d) , and that CD107a expression correlated with NK cell lysis (P = 0.02; Fig. 3e ). These data corroborate the antigenspecific NK cell killing assays and also suggest that CD107a might be a relevant surrogate marker for antigen-specific NK cell cytotoxicity. Taken together, these results demonstrate antigen-specific NK cell activity in both SHIV-and SIV-infected rhesus macaques. The greater NK cell killing in animals infected with SIV mac251 compared with that in SHIV SF162P3 -infected animals may reflect higher viral loads in those animals or virus-specific differences. Indeed, viral loads modestly correlated with both percentage specific lysis and CD107a expression ( Fig. 3f) , suggesting an antigen-driven expansion of SIV Gag-specific NK cells.
Ad26 vectors induce potent memory NK cell responses
We then evaluated whether NK cells are capable of long-term antigenspecific memory after vaccination in the absence of ongoing antigen stimulation. We administered two vaccinations to nine rhesus macaques. The vaccinations were 6 months apart, and each contained 10 9 viral particles of either replication-incompetent Ad26 vectors 39 expressing HIV-1 Env (n = 4) or a DNA-Ad26 prime-boost regimen expressing SIV mac239 Gag (n = 5). Vaccinated animals developed durable Env-and Gag-specific T cell responses to their respective vaccine antigens as expected ( Fig. 4a,b ) and were not boosted or challenged further. Five years after the final vaccination, we necropsied both groups of animals and assessed potential antigen-specific memory NK cell responses in peripheral blood, liver and spleen. As an added control, we evaluated antigen-specific responses to both the vaccine antigen (matched) and the non-vaccine antigen (mismatched-i.e., evaluation of anti-Env responses in Gag-vaccinated animals). At both 10:1 and 5:1 E:T ratios, splenic and hepatic NK cells lysed antigenmatched targets efficiently but exhibited minimal to no reactivity against antigen-mismatched targets (Fig. 4c,d) (P = 0.02 for hepatic NK cells; P = 0.04 for splenic NK cells). In particular, at the 10:1 E:T ratio, splenic NK cells from vaccinated animals showed a median of 27% specific lysis of antigen-matched targets but only 2% specific lysis of antigen-mismatched targets. Consistent with the previous experiment ( Fig. 3) , responses in peripheral blood were marginal (Fig. 4e) . We also observed CD107a responses to the matched but not the mismatched antigen (Fig. 4f,g) , and these data correlated with the killing assays (P = 0.04; Fig. 4h ). The observation of antigen-specific NK cell responses 5 years after vaccination demonstrated the durability of these memory NK cell responses. Memory NK cell responses were comparable in liver and spleen, which contrasts with some evaluations of murine memory NK cell responses showing that memory NK cell activity is restricted to the liver 19, 21, 23 .
Sorting of NK cells eliminated all contaminating CD8 + T cells (Fig. 1d) . To further exclude the remote possibility that contaminating T cells might still have contributed to the observed specific lysis, we carried out parallel cell-killing experiments with CD8 + T cells from the vaccinated animals at 1:1, 0.1:1 and 0.01:1 E:T ratios. These low ratios were chosen to enable simulation of T cell contamination, rather than evaluation of CD8 + T cell-mediated lysis, and little to no killing was observed in these experiments, even at the 1:1 ratio (Fig. 4i) . In re-sort analyses, we observed 0.00% T cell contamination (Fig. 1d) , and even if we consider the flow cytometer's potential theoretical error rate of 1 in 10,000 cells, the 1:1 E:T ratio represents a value 5 logs greater than the maximal possible levels of T cell contamination in any of the NK cell killing assays. These considerations collectively eliminate the possibility that the observed antigen-specific NK cell killing could have been due to contaminating CD8 + T cells.
NK cell memory responses are NKG2 dependent
To determine the relative contributions of various NK cell subsets to the observed memory NK cell responses, we repeated the experiments described in Figure 2 in the presence and in the absence of blocking antibodies to various NK cell receptors. Blocking NKp46 had no observable effect on NK cell-mediated killing, but blocking NKG2A Figure 5 Antigen-specific NK cell killing is dependent on NKG2A and NKG2C. Specific lysis of antigen-pulsed DCs from animals referenced in Figure 2 . Antibodies were added before coculture, and cell killing is shown as a fraction of that in control wells with no blocking (no antibody; normalized to 100%). The figure summarizes data from five independent experiments (mean and s.e.m.). *P < 0.05, Wilcoxon matched-pairs test. and NKG2C markedly reduced NK cell killing of Gag-pulsed DCs by 80% and 75%, respectively (P < 0.05; Fig. 5 ). These data suggest that molecules of the NKG2 family may have a role in target-cell recognition or as coreceptors, analogous to what has been shown for NKG2D in murine memory NK cell responses to haptens 21 .
DISCUSSION
In these studies we observed clear evidence of antigen-specific memory NK cell responses in a primate species. Specifically, we observed anti-Gag and anti-Env NK cell responses in both SIV mac251 -infected and SHIV SF162P3 -infected rhesus macaques that demonstrated NK cell memory generated against active replication of lentiviruses. Furthermore, we found that antigen-specific NK cells were inducible after Ad26 vaccination and that the responses were intact 5 years after vaccination without challenge.
Prior to these studies, antigen-specific NK cell memory had been described only in mice, first in studies showing that transferrable hapten-specific contact hypersensitivity (CHS) in mice lacking T and B cells was dependent on a subpopulation of liver NK cells 21 . This NK cell-mediated CHS was subsequently confirmed in other studies [17] [18] [19] 22 , and NK cell memory has now been demonstrated against vesicular stomatitis virus, HIV-1 and influenza vaccine antigens in mice and has been found to contribute to efficient protection against vaccinia and influenza challenges 19, 23 . Pre-sensitized memorylike NK cells have also been described for MCMV and can expand upon virus exposure and to protect upon adoptive transfer 28 .
Our data expand on these prior studies by showing antigenspecific NK cell memory in primates after both infection and vaccination. As SIV mac251 and SHIV SF162P3 are not natural pathogens in macaques, it seems unlikely that memory responses to these viruses occur through typical NK cell-receptor interactions, such as those mediated by Ly49H-m157 in mice infected with MCMV 28 . The most specific associations with the control of HIV-1 by NK cells have been mediated by KIR; for example, it has been epidemiologically demonstrated that expression of KIR3DS1 on NK cells, in combination with its ligand HLA-Bw4-80I, is associated with slower disease progression 40 , and there is in vitro evidence that KIR3DS1 + NK cells can inhibit HIV-1 replication in vitro 41 . However, KIRmediated effects require interaction with cognate ligands that are often disparately expressed in individuals. Perhaps a more likely pathway is antigen-specific imprinting and recall by a subset of NK memory cells that remain incompletely defined in primates, similar to observations in mice 21 . Our data also suggest that this process may be dependent on NKG2 molecules. Although the full mechanism is unclear, our data indicate that both inhibitory NKG2A and activating NKG2C are required, but the unrelated NKp46 is not. NKG2A is known to bind MHC-I, and absence of this inhibitory interaction results in cell killing, as demonstrated by lysis of MHC-devoid K562 cells. Our data show that NKG2 molecules may also be necessary for antigen-specific killing, which perhaps suggests a distinction specific to memory NK cells. NKG2C expression on human NK cells is associated with subset expansion in response to HCMV but not to other herpesviruses 33 . NKG2C also delineates a subpopulation of 'memory-like' NK cells that use antibody binding for specificity and display enhanced ADCC but become hyporesponsive to cytokine stimulation [42] [43] [44] . These alterations in NK cell function reflect widespread epigenetic modifications with changes in DNA methylation patterns resembling those of cytotoxic T cells 43, 44 . NK cells and NKG2 expression have also been linked to elite control of viremia and reduced acquisition of HIV-1 (refs. 32, 45, 46) . The full role of NK cells in the modulation of HIV or SIV disease and in prevention of disease acquisition also remains uncertain. NK cells are known to lyse both HIV-infected and SIV-infected cells, but it has been difficult to determine the extent to which this occurs in vivo 7, 11, 14, 41 . Increased NK cell function and sensitization in HIV-1-exposed seronegative individuals suggests that these cells could contribute, at least in part, to transmission blocking 29, 30 , although whether antigen specificity is generated in this context is unknown. Contradictory evidence suggests that NK cells may have little to no role in limiting lentivirus transmission or eliminating infected cells 36, 47 , but those studies did not address antigen specificity. Although significant empirical evidence exists, it has been difficult to define a specific role for NK cells in HIV or SIV disease, partly due to the fact that strategies for the full and accurate depletion of NK cells in SIV-infected macaque models are currently lacking 15, 48 . SIV-specific NK cell activity positively correlated with plasma viral load, which indicates that the presence of antigen can probably influence at least the magnitude of antigen-specific NK cell responses. The longevity of memory NK cell responses after Ad26 vaccination in the absence of virus replication also suggests that ongoing antigenic stimulation is not necessarily required to maintain long-term responses. Future studies will be necessary to determine the kinetics and full anatomic distribution of antigen-specific NK cells after lentivirus infection and vaccination, as well as the relative contributions to disease modulation and the prevention of virus acquisition.
Overall, our findings show antigen-specific NK cell responses in primates after both infection and vaccination. Although antigenspecific NK cells are likely modulated by ongoing virus replication in infected animals, the finding that Ad26 vaccination induced true memory NK cells that were maintained for 5 years after vaccination is particularly notable. The longevity, functionality and specificity of these responses suggest their potential utility in the development of vaccines against both HIV-1 and other pathogens. Further research to evaluate the protective efficacy of these responses in primates and to define the detailed molecular mechanisms of target-cell engagement is warranted. Regardless, our new data and the extensive work previously done in mice suggest that NK cell memory could be conserved among mammalian species and underscore the incomplete understanding and heterogeneity of innate versus adaptive immune responses.
METHODS
Methods and any associated references are available in the online version of the paper.
